Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.39 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21389869 | 0.90 | SCN5A (0.47) | GAAMAPTCES2CES1SMN1; SMN2 | |
| SCHEMBL21389877 | 0.90 | BLM (0.53) | GAAMAPTSMN1; SMN2BLMCYP2C19 | |
| SCHEMBL20315398 | 0.80 | BLM (0.50) | GAAMAPTSMN1; SMN2BLMCYP2C19 | |
| SCHEMBL21389886 | 0.77 | LMNA (0.46) | MAPTCA2CA4CA5AMEN1 | |
| SCHEMBL21389873 | 0.77 | LMNA (0.47) | MAPTMEN1KMT2AABCB11CYP3A4 | |
| SCHEMBL1924747 | 0.74 | MAPT (0.57) | GAAMAPTCA1CA2CA9 | |
| SCHEMBL613598 | 0.74 | GAA (0.79) | GAAMAPTCA12CA1CA2 | |
| SCHEMBL14369512 | 0.72 | BLM (0.45) | GAAMAPTSMN1; SMN2BLMCYP2C19 | |
| Butane SCHEMBL924011 | 0.72 | SRC (0.59) | CYP2C19MEN1KMT2APOLBALDH1A1 | |
| SCHEMBL21389870 | 0.72 | NQO1 (0.58) | CES2CES1SMN1; SMN2BLMCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10862169-B2 | Phosphorus electrolytic solution containing magnesium ions | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2020-12-08 | — | — | US | disclosed |
| US-20190296396-A1 | PHOSPHORUS ELECTROLYTIC SOLUTION CONTAINING MAGNESIUM IONS | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10862169-B2 | Phosphorus electrolytic solution containing magnesium ions | PEF1, RER1, AFF1 | GAA 3578/4885MAPT 4791/4885CES2 1928/4885 |
| US-20190296396-A1 | PHOSPHORUS ELECTROLYTIC SOLUTION CONTAINING MAGNESIUM IONS | PEF1, RER1, AFF1 | GAA 3578/4885MAPT 4791/4885CES2 1928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.